In addition to the prolonged pain and suffering endured by sickle cell patients, a Washington University School of Medicine study has concluded that there could be a significant impact on cognitive ...

No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Research and Development (R&D) Expenses: R&D expenses were $82.8 million for the fourth quarter of 2024, compared to $77.5 million for the fourth quarter of 2023, and $301.3 million for the full year ...

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

CLEVELAND, Ohio (WOIO) - The American Red Cross Northern Ohio Chapter is asking for diverse blood donations. Certain blood types are unique to specific racial and ethnic groups. This means donor ...

Q4 2024 Management View CEO Brian Goff highlighted the company's strategic focus on expanding the Pyrukynd franchise, with significant growth expected from the potential approval and launch in ...

AM Best has assigned a Financial Strength Rating of A (Excellent) and a Long-Term Issuer Credit Rating of "a" (Excellent) to ...

Is the Only HBCU To Ever Hold the R1 Designation Reaches Research One Researcher conducts experiment in university ...

CRISPR Therapeutics AG (CRSP) stock jumped over 9% this week after delivering strong Q4 2024 results ahead of schedule. The ...

ACTIVATE-Kids is the First Study to Demonstrate Efficacy of an Oral Therapy for Children with PK Deficiency Who Are Not Regularly Transfused –– ...

Tamil Nadu launches a statewide leprosy detection drive from February 13 to 28 aiming to curb rising cases through intensive screenings in rural and urban areas ...

More than 2.1 billion young people are at the heart of the NCD crisis. Interventions during early childhood and adolescence can have significantly beneficial, long-lasting health outcomes, and ...